Latest risk assessment
 |
Emergence of hypervirulent Klebsiella pneumoniae ST23 carrying carbapenemase genes in EU/EEA countries
Date of publication: 17 March 2021 This document assesses the risk associated with the dissemination of carbapenemase-producing hypervirulent Klebsiella pneumoniae (hvKp) of sequence type (ST) 23 and other STs in the European Union/European Economic Area (EU/EEA).
|
Technical reports on COVID-19
 |
Risk of SARS-CoV-2 transmission from newly-infected individuals with documented previous infection or vaccination
Date of publication: 29 March 2021 The aim of this document is to provide a summary of the available scientific evidence on the risk of SARS-CoV-2 transmission to susceptible contacts from infected individuals with documented previous infection or vaccination.
|
|
 |
Rollout of COVID-19 vaccines in the EU/EEA: challenges and good practice
Date of publication: 29 March 2021 The aim of this report is to share the challenges countries are facing with the rollout of the COVID-19 vaccine deployment process. It also aims to share lessons learned and good practice that countries have put in place to mitigate the challenges.
|
|
 |
Overview of the implementation of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA
Date of publication: 29 March 2021 This report provides an updated overview of the progress of national COVID-19 vaccination strategies in EU/EEA countries, including: vaccine uptake; current vaccination phases and priority groups; vaccination strategies and policies; and vaccination monitoring systems, including the use of vaccination certificates and the coordination between health authorities and civil protection authorities with vaccination rollout.
|
|
 |
Stress test on logistical aspects of COVID-19 vaccination deployment plans for the Western Balkans: final report
Date of publication: 18 March 2021 ECDC, together with the European Commission’s Directorate-General for Health and Food Safety, and supported by the Commission’s Directorate-General for Neighbourhood and Enlargement Negotiations, organised a stress test of the logistical aspects of COVID-19 vaccination deployment plans for the Western Balkans.
|
|
|
Introducing a coherent European framework for tuning COVID-19 response measures
Date of publication: 17 March 2021 This document presents a coherent, yet non-prescriptive framework for tuning COVID-19 response measures in the European Union and European Economic Area (EU/EEA). Its aim is to ensure efficiency and encourage public trust and compliance, while continuing to protect the health of European citizens.
|
|
|
Considerations on the use of self-tests for COVID-19 in the EU/EEA
Date of publication: 17 March 2021 This document outlines the public health considerations for the use of self-tests to detect SARS-CoV-2 by public health authorities in the European Union/European Economic Area (EU/EEA). Only rapid antigen detection tests (RADTs) for self-testing for direct detection of SARS-CoV-2 virus particles in infectious individuals are considered within this document.
|
|
|
One-day in-action review (IAR) protocol in the context of COVID-19
Date of publication: 12 March 2021 This document aims to support the implementation of in-action reviews (IARs) focused on the public health response to COVID-19. IARs seek to identify best practice and lessons learned, while applying these insights in a tighter time-scale to improve the outcome of an ongoing response. In-action reviews may also include a ‘forward-look’ to assess strategic options in the upcoming phases of the pandemic.
|
|
|
Guidance for COVID-19 quarantine and testing of travellers
Date of publication: 12 March 2021 This document provides guidance based on scientific evidence regarding quarantine and testing of travellers in EU/EEA countries in the context of the emergence of SARS-CoV-2 variants of concern (VOCs). It follows the provisions of the Council Recommendation (EU) 2021/119 of 1 February 2021 amending Recommendation (EU) 2020/1475 on a coordinated approach to the restriction of free movement in response to the COVID-19 pandemic.
|
|
 |
Methods for the detection and identification of SARS-CoV-2 variants
Date of publication: 3 March 2021 This technical guidance provides guidance to laboratories, microbiology experts and relevant stakeholders in making decisions on establishing or scaling up capability and capacity to detect and identify circulating SARS-CoV-2 variants, and in making decisions on which technologies to use and for which objective.
|
|
| Other technical reports | ||
|
Assessment tool for joint One Health country visits in relation to antimicrobial resistance
Date of publication: 30 March 2021 This updated assessment tool, which outlines the indicators for human health and the joint parts of the country visits, should be used in conjunction with respective EC assessment tools for the veterinary and environmental sectors.
|
|
|
The sustainable development goals and hepatitis B and C in the EU/EEA
Date of publication: 29 March 2021 In order to monitor progress towards the United Nations Sustainable Development Goals 2030 target to combat viral hepatitis, this report provides data on hepatitis B and C prevention, incidence, diagnosis, treatment, cure/viral suppression, and mortality in European Union/European Economic Area (EU/EEA) countries with data collected in 2019.
|
|
 |
Joint ECDC, EFSA and EURL Lm report: European Listeria typing exercise (ELiTE)
Date of publication: 24 March 2021 The ‘European Listeria Typing Exercise’ (ELiTE) is a collaborative study initiated in 2010 as a multi-sectorial, multi-centre exercise. This report presents the objectives, methods, results, and conclusions of the study, as well as recommendations for further studies.
|
|
 |
Technologies, strategies and approaches for testing populations at risk of sexually transmitted infections in the EU/EEA
Date of publication: 10 March 2021 This report presents the results of a systematic literature review investigating the impact of novel strategies and approaches (using existing and/or novel testing technologies) on access to testing, testing coverage, and linkage to care of key populations at-risk for sexually transmitted infections (STIs).
|
|
 |
HIV Pre-Exposure Prophylaxis in the EU/EEA and the UK: implementation, standards and monitoring
Date of publication: 5 March 2021 This operational guidance document provides practical recommendations and key considerations to inform the development and implementation of PrEP programmes at national and sub-national levels throughout the EU/EEA.
|
|
| Surveillance reports | ||
 |
Influenza virus characterisation – Summary Europe, February 2021
Date of publication: 11 March 2021 ECDC’s influenza virus characterisation reports are published periodically and give an overview of circulating influenza viruses. They provide details on the current vaccine strains, summarise the development of the viruses since the last report, and closely follow the main developments for the ongoing influenza season. Virus characterisation reports are primarily intended for influenza virologists and epidemiologists.
|
|
 |
Tuberculosis surveillance and monitoring in Europe 2021 –2019 data
Date of publication: 22 March 2021 This report provides an overview of the latest TB epidemiological situation and is published jointly by the WHO Regional Office for Europe and the European Centre for Disease Prevention and Control (ECDC).
|
|
 |
Annual Epidemiological Report series on communicable diseases in Europe
The Annual Epidemiological Report series on communicable diseases in Europe provides a comprehensive summary of surveillance data for EU/EEA countries. It is mainly intended for public health professionals and policymakers involved in infectious disease prevention and control. All disease chapters for 2014-2019 are available on the ECDC website Published in March: |
|
 |
ECDC communicable disease threats report
Date of publication: every Friday The ECDC communicable disease threats report is a weekly bulletin intended for epidemiologists and health professionals in the area of communicable disease prevention and control. Summarising information gathered by ECDC through its epidemic intelligence activities regarding communicable disease threats of concern to the European Union, it also provides updates on the global situation and changes in the epidemiology of communicable diseases with potential to affect Europe, including diseases that are the focus of eradication efforts. |
|
| Scientific peer-reviewed publications | ||
 |
Publications by ECDC staff in scientific journals
All scientific peer-reviewed publications produced by ECDC staff on behalf of the Centre for the period January 2005 – December 2020 are available online.
|
|